Advertisement

Topics

NantCell, Inc. Company Profile

03:00 EDT 18th June 2019 | BioPortfolio

NantCell, an entity controlled by Dr. Patrick Soon-Shiong, is an immuno-oncology company focused on the discovery of innovative antibody, T cell and NK cell based treatments by developing molecularly targeted therapeutics, based on the proteomic profile of the patient's tumor, independent of the cancer's anatomical type.


News Articles [9 Associated News Articles listed on BioPortfolio]

NantCell completes second round, gets $30mm from Celgene

Oncology immunotherapy developer NantCell Inc. (a NantHealth company) raised $30mm through a crossover investment from Celgene. This is the second such round for NantCell and Celgene; NantCell was fou...

NantCell Announces New $CELG Investment https://www.businesswire.com/news/home/20190104005541/en/NantCell-Announces-New-Celgene-Investment …

NantCell Announces New $CELG Investment https://www.businesswire.com/news/home/20190104005541/en/NantCell-Announces-New-Celgene-Investment …

Celgene invests $30M in NantCell weeks before BMS bid

Celgene invested $30M in NantCell weeks before BMS bid

After two big Nant blow-ups from PSS: $NH NantHealth -97% since IPO $NK NantKwest -95% since IPO Here comes another unicorn NantCell at $4B valuation and its miraculous sextuple combo! https://twitter.com/AndyBiotech/status/1060543276971896832 … A

After two big Nant blow-ups from PSS: $NH NantHealth -97% since IPO $NK NantKwest -95% since IPO Here comes another unicorn NantCell at $4B valuation and its miraculous sextuple combo! https://...

FDA's concern about difficulty to isolate the treatment effect from single arm combination trial in $KPTI AdCom BD should also be a big warning sign to $NK/Nantcell's miraculous sextuple combo! https://twitter.com/AndyBiotech/status/1060543276971896832

FDA's concern about difficulty to isolate the treatment effect from single arm combination trial in $KPTI AdCom BD should also be a big warning sign to $NK/Nantcell's miraculous sextuple combo! h...

Aethlon Medical Names GlobeImmune’s Timothy Rodell as Interim CEO

Aethlon Medical has appointed Timothy Rodell as its interim CEO, the company announced Thursday. Rodell was previously president and CEO of Louisville, CO-based GlobeImmune from 2002 to 2016. He remai...

NantKwest Chairman & CEO Dr. Patrick Soon-Shiong to Present Vision for Next Generation Natural Killer Cell Therapies During Keynote Address at Innate Killer Summit

NantKwest (Nasdaq:NK), a leading clinical-stage, natural killer cell based therapeutics company, today announced that the company’s Chairman & CEO, Dr. Patrick ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

NantCell, Inc.

NantCell, an entity controlled by Dr. Patrick Soon-Shiong, is an immuno-oncology company focused on the discovery of innovative antibody, T cell and NK cell based treatments by de...

NantCell

NantCell, a member of the NantWorks ecosystem of companies, is a biopharmaceutical company focused on the discovery of innovative molecularly targeted therapies based on the uniqu...

More Information about "NantCell, Inc." on BioPortfolio

We have published hundreds of NantCell, Inc. news stories on BioPortfolio along with dozens of NantCell, Inc. Clinical Trials and PubMed Articles about NantCell, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NantCell, Inc. Companies in our database. You can also find out about relevant NantCell, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...


Corporate Database Quicklinks



Searches Linking to this Company Record